Now that daratumumab is being used in the clinic, myeloma specialists have more experience with its use. Learn why a new test is in the works to prevent patients from being taken off the drug when they are actually responding and which combinations are the most effective. Dr. Torben Plesner has been running daratumumab clinical trials since its inception and is a myeloma expert with extensive experience with the drug. Thanks to our episode sponsor, Takeda Oncology